Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global HPV Associated Disorders Market: By Indication: Cervical Intraepithelial Neoplasia (CIN), Cervical Cancer, Anal Intraepithelial Neoplasia (AIN), Anal Cancer, Genital Warts; By Therapy; By Distributional Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Competitive Landscape; Industry Events and Developments

Global HPV Associated Disorders Market Outlook

The global HPV associated disorders market was estimated at almost USD 16 billion in 2020. The industry is further expected to grow at a CAGR of 5% during the forecast period of 2022-2027.

 

Global HPV Associated Disorders Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

With the increase in the incidences of HPV-related diseases and the improvement in its treatment procedures, the global HPV associated disorders industry is expected to witness a steady growth over the forecast period.

 

Properties and Applications

HPV is a viral infection that often triggers the growth of the skin or mucous membrane (warts). There are over 100 human papillomaviruses (HPV) varieties. Many forms of cancers have been related to HPV infection, including anus, penis, uterus, vulva, and back of the throat (oropharyngeal).

 

Global HPV Associated Disorders Market By Indication

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The global HPV associated disorders industry can be broadly categorised based on segments like indication, therapy, distributional channel, and region.

  • Indication:
    • Cervical Intraepithelial Neoplasia (CIN)
    • Cervical Cancer
    • Anal Intraepithelial Neoplasia (AIN)
    • Anal Cancer
    • Genital Warts
    • Others 
  • Therapy: 
    • Prevention
    • Treatment
  • Distributional Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

The EMR report looks into the regional HPV associated disorders markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global HPV Associated Disorders Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The increased government initiatives and the growing funding for cancer research are expected to aid the global HPV associated disorders industry. However, the increased investment in R&D associated with oncologic diseases offers significant growth opportunities for the industry growth in the future. The lack of knowledge regarding the diagnosis and treatment of such diseases and the high treatment costs are some factors that may hinder the industry growth over the forecast period.
 
Hospital pharmacies, among other distribution channels, are expected to account for the largest share in the industry owing to the growing expenditure in healthcare infrastructure in both the developing and underdeveloped economies. Region-wise, while North America leads the industry, the Asia Pacific is expected to grow at the highest CAGR over the forecast period owing to the development in the healthcare infrastructure in the region, along with the rising consumer expenditure power. 

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global HPV associated disorders industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • F. Hoffmann-La Roche AG
  • Merck & Co., Inc. 
  • GlaxoSmithKline plc
  • Biocon Limited
  • AstraZeneca plc
  • Others

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Indication, Therapy, Distribution Channel, Region
Breakup by Indication Cervical Intraepithelial Neoplasia (CIN), Cervical Cancer, Anal Intraepithelial Neoplasia (AIN), Anal Cancer, Genital Warts, Others
Breakup by Therapy Prevention, Treatment
Breakup by Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered F. Hoffmann-La Roche AG, Merck & Co., Inc. , GlaxoSmithKline plc, Biocon Limited, AstraZeneca plc, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global HPV Associated Disorders Market Analysis

    8.1    Key Industry Highlights
    8.2    Global HPV Associated Disorders Historical Market (2017-2021) 
    8.3    Global HPV Associated Disorders Market Forecast (2022-2027)
    8.4    Global HPV Associated Disorders Market by Indication
        8.4.1    Cervical Intraepithelial Neoplasia (CIN)
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Cervical Cancer
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Anal Intraepithelial Neoplasia (AIN)
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Anal Cancer
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
        8.4.5    Genital Warts
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2017-2021)
            8.4.5.3    Forecast Trend (2022-2027)
        8.4.6    Others
    8.5    Global HPV Associated Disorders Market by Therapy
        8.5.1    Prevention
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Treatment
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
    8.6    Global HPV Associated Disorders Market by Distribution Channel
        8.6.1    Hospital Pharmacies
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Retail Pharmacies
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Online Pharmacies
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
    8.7    Global HPV Associated Disorders Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    F. Hoffmann-La Roche AG
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Merck & Co., Inc.  
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3     GlaxoSmithKline plc
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Biocon Limited.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    AstraZeneca plc
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Global HPV Associated Disorders Market: Key Industry Highlights, 2016 and 2026
2.    Global HPV Associated Disorders Historical Market: Breakup by Indication (USD Billion), 2017-2021
3.    Global HPV Associated Disorders Market Forecast: Breakup by Indication (USD Billion), 2022-2027
4.    Global HPV Associated Disorders Historical Market: Breakup by Therapy (USD Billion), 2017-2021
5.    Global HPV Associated Disorders Market Forecast: Breakup by Therapy (USD Billion), 2022-2027
6.    Global HPV Associated Disorders Historical Market: Breakup by Distribution Channel (USD Billion), 2017-2021
7.    Global HPV Associated Disorders Market Forecast: Breakup by Distribution Channel (USD Billion), 2022-2027
8.    Global HPV Associated Disorders Historical Market: Breakup by Region (USD Billion), 2017-2021
9.    Global HPV Associated Disorders Market Forecast: Breakup by Region (USD Billion), 2022-2027
10.    North America HPV Associated Disorders Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    North America HPV Associated Disorders Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Europe HPV Associated Disorders Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Europe HPV Associated Disorders Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Asia Pacific HPV Associated Disorders Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Asia Pacific HPV Associated Disorders Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Latin America HPV Associated Disorders Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Latin America HPV Associated Disorders Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Middle East and Africa HPV Associated Disorders Historical Market: Breakup by Country (USD Billion), 2017-2021
19.    Middle East and Africa HPV Associated Disorders Market Forecast: Breakup by Country (USD Billion), 2022-2027
20.    Global HPV Associated Disorders Market Structure

Key Questions Answered in the Report

The global HPV associated disorders market reached a value of USD 16 billion in 2020.

The market is projected to grow at a CAGR of nearly 5% in the forecast period of 2022-2027.

The major drivers of the industry include rising disposable incomes, increasing population, rising investment in R&D, and the growing expenditure in the healthcare infrastructure.

The increased government initiatives and the rising funding for cancer research are expected to be the key trends guiding the growth of the industry.

North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market, with North America dominating the market.

The leading indications segments in the industry include cervical intraepithelial neoplasia (CIN), cervical cancer, anal intraepithelial neoplasia (AIN), anal cancer, and genital warts, among others.

The major therapies included in the market are prevention and treatment.

The significant distribution channels in the industry include hospital pharmacies, retail pharmacies, and online pharmacies.

The leading players in the market are F. Hoffmann-La Roche AG, Merck & Co., Inc., GlaxoSmithKline plc, Biocon Limited, and AstraZeneca plc, among others.

Analyst Review

The global HPV associated disorders market attained a value of USD 16 billion in 2020, driven by the rising healthcare infrastructure. Aided by the increased government initiatives supporting the growth of the healthcare sector, the industry is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 5%.

EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on indication, the global market for HPV associated disorders can be segmented into cervical intraepithelial neoplasia (CIN), cervical cancer, anal intraepithelial neoplasia (AIN), anal cancer, and genital warts, among others. By therapy, the industry can be segmented into prevention and treatment. On the basis of distribution channels, the industry can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The major regional markets for HPV associated disorders are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above industry include F. Hoffmann-La Roche AG, Merck & Co., Inc. , GlaxoSmithKline plc, Biocon Limited, and AstraZeneca plc, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER